Accuracy assessment of PSA methods must be based on clinical instead of artificial samples - A response to AW Roddam et al., Ann Clin Biochem 2006; 43: 35-48 [2]

Annals of Clinical Biochemistry

Volumn 43, Issue 5, 2006, Pages 421-422

  Stephan, Carsten ^a   Semjonow, Axel ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CALIBRATION; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; LETTER; MEDICAL ERROR; MEDICAL SOCIETY; PHYSICIAN; PRIORITY JOURNAL; REFERENCE VALUE; SAMPLING; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

CLINICAL CHEMISTRY TESTS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33749512355     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306778520089     Document Type: Letter

References (8)

1. Roddam AW, Rimmer J, Nickerson C, Ward AM. Prostate-specific antigen: bias and molarity of commercial assays for PSA in use in England. Ann Clin Biochem 2006; 43: 35-48
2. Roddam AW, Price CP, Allen NE, Ward AM. Assessing the clinical impact of prostate-specific antigen assay variability and nonequimolarity: a simulation study based on the population of the United Kingdom. Clin Chem 2004; 50: 1012-6
3. Clinical Laboratory Strategies, 2004, 9
4. Evaluation of Matrix Effects. Approved Guideline, Document EP14-A2 from the American National Standards Institute at http://webstore.ansi.org/ ansidocstore/product.asp?sku=EP14-A2
5. Stephan S, Klaas M, Muller C, Schnorr D, Loening SA, Jung K. Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update. Clin Chem 2006; 52: 59-64
6. http://egtm.web.med.uni-muenchen.de/index2.html
7. http://www.nacb.org/lmpg/tumor/chp3b_prostate.doc
8. Beckman Coulter Symposium. ISOBM Conference, 2005